'To prone or not to prone' in severe ARDS: Questions answered, but others remain by Tekwani, SS & Murugan, R
Tekwani and Murugan Critical Care 2014, 18:305
http://ccforum.com/content/18/3/305JOURNAL CLUB CRITIQUE‘To prone or not to prone’ in severe ARDS:
questions answered, but others remain
Seema S Tekwani1 and Raghavan Murugan1,2*
University of Pittsburgh Department of Critical Care Medicine: Evidence-Based Medicine Journal Club, edited by Sachin YendeExpanded abstract
Citations
Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A,
Boulain T, Mercier E, Badet M, Mercat A, Baudin O,
Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J,
Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier
M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L,
Ayzac L, PROSEVA Study Group: Prone positioning in
severe acute respiratory distress syndrome. N Engl J
Med 2013, 368:2159.
Background
Previous trials involving patients with the acute respira-
tory distress syndrome (ARDS) have failed to show a
beneficial effect of prone positioning during mechanical
ventilator support on outcomes. We evaluated the effect
of early application of prone positioning on outcomes in
patients with severe ARDS.
Methods
Objective: The objective was to evaluate the effect of early
application of prone position on mortality in patients with
severe ARDS.
Design: The PROSEVA group conducted a multicenter,
prospective, randomized controlled trial.
Setting: Patients with ARDS were recruited from 26
ICUs in France and one ICU in Spain.
Subjects: The subjects were critically ill patients admitted
to the ICU with respiratory failure requiring mechanical
ventilation for severe ARDS. Severe ARDS criteria - an
arterial partial pressure of oxygen/fraction of inspired
oxygen (PaO2/FiO2) ratio of less than 150 mm Hg, an FiO2
of at least 0.6, a positive end-expiratory pressure of at least* Correspondence: muruganr@ccm.upmc.edu
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20145 cm of water, and a tidal volume of about 6 mL per
kilogram of predicted body weight - were confirmed after
12 to 24 hours of mechanical ventilation in the participating
ICUs. Subjects were eligible after 12 to 24 hours of
stabilization and were randomly assigned to either the
prone group or the supine group.
Intervention: Four hundred sixty-six patients with severe
ARDS underwent prone position ventilation of at least
16 hours or ventilation in the supine position. Patients
assigned to the prone group were manually turned in
standard ICU beds to the prone position within the first
hour of random assignment and were placed prone for
at least 16 consecutive hours. Standard ventilator proto-
cols and weaning protocols were implemented for study
participants.
Outcomes: The primary outcome was the proportion of
patients who died from any cause within 28 days after
random assignment.Results
In total, 237 patients were assigned to the prone group
and 229 patients were assigned to the supine group. The
28-day mortality rates were 16% in the prone group and
32.8% in the supine group (P <0.001). The hazard ratio for
death with prone ventilation was 0.39 (95% CI 0.25 to
0.63). Unadjusted 90-day mortality rates were 23.6% in the
prone group and 41% in the supine group (P <0.001), with
a hazard ratio of 0.44 (95% CI 0.29 to 0.67). The incidence
of complications did not differ significantly between the
groups, except for the incidence of cardiac arrests, which
was higher in the supine group.Conclusions
In patients with severe ARDS, early application of pro-
longed prone-positioning sessions significantly decreased
28-day and 90-day mortality.d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Prone position ventilation (PPV) has been shown to im-
prove oxygenation in many animal and human studies of
severe acute respiratory distress syndrome (ARDS) [1,2].
The benefits of PPV have been attributed to multiple mech-
anisms. First, in the supine position, there is more
expansion of ventral alveoli compared to dorsal alveoli, and
this effect is more profound in patients with ARDS because
increased lung weight compresses dorsal alveoli. At the
same time, due to the effect of gravity, blood flow is highest
in these dorsal lung fields causing a ventilation perfusion
mismatch. When the patient is placed in the prone
position, the pressure gradient from ventral to dorsal
regions of the lung is reduced and trans-pulmonary
pressures are more uniformly distributed, making ventila-
tion more uniform [3]. Second, with PPV, improved ventila-
tion in previously dependent areas in the dorsal region now
matches the sustained higher dorsal perfusion, thus signifi-
cantly reducing the ventilation/perfusion mismatch [4].
Third, PPV reduces alveolar collapse and hyperinflation by
decreasing lung compression by caudal displacement of
abdominal organs and also decreasing the weight of the
heart on the left lower lobe of the lung parenchyma [5].
Fourth, PPV improves bronchial drainage and aids secre-
tion clearance by the effects of straightening the larger
airways with gravity assistance [6]. Finally, PPV decreases
chest wall compliance, thus improving functional residual
capacity [7].
Many clinical trials have been conducted to assess the
clinical benefits of PPV in patients with ARDS. Gattinoni
and colleagues [8] conducted the first clinical trial and
demonstrated improvement in oxygenation in patients
on PPV. Similar results of improved oxygenation have
been found in another study [9]. However, none of these
earlier studies has been able to show any difference in
mortality. Proponents of PPV feel that the initial studies
were fraught with poor study design as they did not
clearly define study protocols and enrolled a hetero-
geneous group of patients with less severe ARDS and
patients with non-ARDS-related hypoxemic respiratory
failure [10]. Other criticisms include late implementation
of PPV after onset of ARDS and shorter duration of PPV
(about 6 to 8 hours per day).
Subsequent randomized controlled trials attempted to
enroll patients earlier (Guérin and colleagues [9]) and
for longer duration [11]. However, these studies were
underpowered to detect statistically significant effects on
mortality [9]. Taccone and colleagues [12] enrolled
patients with arterial partial pressure of oxygen/fraction
of inspired oxygen (PaO2/FiO2) ratios of less than 100,
with the intervention group receiving PPV for 20 hours
per day. However, this trial did not show any mortality
benefit; on the contrary, it showed a significant increase
in adverse events with PPV [12]. Nevertheless, meta-analysis and subgroup analyses of patients with severe
ARDS have shown a trend toward mortality benefit [13].
Thus, PPV remained a grade 2B recommendation in the
2012 Surviving Sepsis Guidelines and in the primary role
as a rescue therapy in patients with severe ARDS [14].
In this multicenter clinical trial, Guérin and colleagues
(see ‘Citation’ above) examined whether PPV has any
beneficial effects in the sickest of ARDS patients with
severe hypoxemia when PPV was initiated within
24 hours after onset of ARDS and sustained for longer
duration of at least 16 hours per day. Strengths of the
study include a well-conducted multicenter trial, inclu-
sion of a homogenous group of patients with severe
ARDS, use of lung protective ventilation in both arms,
and use of standard ventilator weaning protocols. The
authors were able to show a remarkable benefit of PPV
with a huge effect size of 51% relative risk reduction
(RRR) in mortality at 28 days with a number needed to
treat of 6. This mortality reduction persisted at 90 days
(23.6% versus 41%; P <0.001).
Important limitations of the study include imbalances in
baseline characteristics with more severely ill patients
enrolled in the control group, as evidenced by higher
Sequential Organ Failure Assessment scores and increased
vasopressor requirement, compared with the PPV group.
This difference between the groups could have biased the
result toward benefit for the PPV group. In addition, the
PPV group was noted to have received more neuromuscu-
lar blockers, which may have magnified the treatment effect
as use of neuromuscular blockers has been shown to im-
prove mortality in patients with ARDS [15]. This makes us
further question the care received for the supine patients as
blinding was impossible and may have influenced the care
received by the control group. Recent meta-analysis on
PPV predicted a mortality benefit of approximately 16%
RRR in severe ARDS patients with a PaO2/FiO2 ratio of less
than 100, but the large effect size of more than 50% RRR in
the PROSEVA (Proning Severe ARDS Patients) trial has
not been reported with any critical care intervention ques-
tioning the biologic plausibility of such a huge benefit [13].
This finding might have resulted as a consequence of pos-
sible inflated control group mortality (32%) as current
ARDS studies report much lower mortality rates.
It is important to note that the study was conducted in
an environment of practitioners who are highly skilled
and trained in prone ventilation. Management of the
prone patient is an acquired skill and is technically
challenging as detailed in the video accompanying the
article. Widespread implementation of PPV requires the
health-care system to be equipped with additional
resources like training and education, PPV-specific proto-
cols, and expertise to avoid serious adverse events in order
to replicate the results and low complication rate seen in
the PROSEVA study. The PROSEVA trial also suggests
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least 0.6 and positive end-expiratory pressure of at least
5), which would require initiating PPV in many patients
with ARDS and hence tremendous education efforts and
resources for widespread implementation.
Recommendation
Although the results of the PROSEVA trial need to be
replicated, the study findings suggest that using PPV
earlier, more often, and for longer durations in patients
with severe ARDS results in better outcomes than does
offering PPV as a rescue maneuver and a last-ditch
effort.
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